LBLorena S. Beese

Lorena S. Beese

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lorena S. Beese has a total of 24 co-authors. Here are the top co-authors by number of shared publications:

  • Patrick J. Casey

    Program in Cancer and Stem Cell Biology, Duke-NUS Medical School, 8 College Road, Singapore 169857, Singapore

    3 shared publications
  • Stephen B. Long

    Department of Biochemistry, Duke University Medical Center, Durham, North Carolina 27710, USA

    3 shared publications
  • Jeffrey S. Taylor

    Department of Biochemistry, Duke University Medical Center, Durham, NC 27710, USA

    2 shared publications
  • Kimberly L. Terry

    Department of Biochemistry, Duke University Medical Center, Durham, NC, 27710, USA

    2 shared publications
  • Michael A. Hast

    Department of Biochemistry, Duke University Medical Center, Box 3711, Durham, NC 27710, USA

    2 shared publications
  • Andrew D. Hamilton

    Department of Chemistry, Yale University, 225 Prospect Street, P.O. Box 208107, New Haven, CT 06520-8107 (USA), Fax: (+1) 203-432-6144

    1 shared publication

Latest Publications

  • Structural Basis for Binding and Selectivity of Antimalarial and Anticancer Ethylenediamine Inhibitors to Protein Farnesyltransferase

    by Michael A. Hast, Steven Fletcher, Christopher G. Cummings, Erin E. Pusateri, Michelle A. Blaskovich, Kasey Rivas, Michael H. Gelb, Wesley C. Van Voorhis, Said M. Sebti, Andrew D. Hamilton, et al.


  • Open Access

    Ligand-induced conformational changes in a thermophilic ribose-binding protein

    by Matthew J Cuneo, Lorena S Beese, Homme W Hellinga

    Members of the periplasmic binding protein (PBP) superfamily are involved in transport and signaling processes in both prokaryotes and eukaryotes. Biological responses are typically mediated by ligand-induced conformational changes in which the binding event is coupled to a hinge-bending motion that brings together two domains in a closed form. In all PBP-mediated biological processes, downstream partners recognize the closed form of the protein. This motion has also been exploited in protein engineering experiments to construct biosensors that transduce ligand binding to a variety of physical signals. Understanding the mechanistic details of PBP conformational changes, both global (hinge bending, twisting, shear movements) and local (rotamer changes, backbone motion), therefore is not only important for understanding their biological function but also for protein engineering experiments.


  • The structural basis for the mutagenicity of O 6 -methyl-guanine lesions

    by Joshua J. Warren, Lawrence J. Forsberg, Lorena S. Beese

    Methylating agents are widespread environmental carcinogens that generate a broad spectrum of DNA damage. Methylation at the guanine O 6 position confers the greatest mutagenic and carcinogenic potential. DNA polymerases insert cytosine and thymine with similar efficiency opposite O 6 -methyl-guanine (O6MeG). We combined pre-steady-state kinetic analysis and a series of nine x-ray crystal structures to contrast the reaction pathways of accurate and mutagenic replication of O6MeG in a high-fidelity DNA polymerase from Bacillus stearothermophilus . Polymerases achieve substrate specificity by selecting for nucleotides with shape and hydrogen-bonding patterns that complement a canonical DNA template. Our structures reveal that both thymine and cytosine O6MeG base pairs evade proofreading by mimicking the essential molecular features of canonical substrates. The steric mimicry depends on stabilization of a rare cytosine tautomer in C·O6MeG–polymerase complexes. An unusual electrostatic interaction between O-methyl protons and a thymine carbonyl oxygen helps stabilize T·O6MeG pairs bound to DNA polymerase. Because DNA methylators constitute an important class of chemotherapeutic agents, the molecular mechanisms of replication of these DNA lesions are important for our understanding of both the genesis and treatment of cancer.


  • Open Access

    Structure of mammalian protein geranylgeranyltransferase type‐I

    by Jeffrey S. Taylor, T. Scott Reid, Kimberly L. Terry, Patrick J. Casey, Lorena S. Beese

    Protein geranylgeranyltransferase type‐I (GGTase‐I), one of two CaaX prenyltransferases, is an essential enzyme in eukaryotes. GGTase‐I catalyzes C‐terminal lipidation of >100 proteins, including many GTP‐ binding regulatory proteins. We present the first structural information for mammalian GGTase‐I, including a series of substrate and product complexes that delineate the path of the chemical reaction. These structures reveal that all protein prenyltransferases share a common reaction mechanism and identify specific residues that play a dominant role in determining prenyl group specificity. This hypothesis was confirmed by converting farnesyltransferase (15‐C prenyl substrate) into GGTase‐I (20‐C prenyl substrate) with a single point mutation. GGTase‐I discriminates against farnesyl diphosphate (FPP) at the product turnover step through the inability of a 15‐C FPP to displace the 20‐C prenyl‐peptide product. Understanding these key features of specificity is expected to contribute to optimization of anti‐cancer and anti‐parasite drugs.


  • Processive DNA synthesis observed in a polymerase crystal suggests a mechanism for the prevention of frameshift mutations

    by Sean J. Johnson, Jeffrey S. Taylor, Lorena S. Beese

    DNA polymerases replicate DNA by adding nucleotides to a growing primer strand while avoiding frameshift and point mutations. Here we present a series of up to six successive replication events that were obtained by extension of a primed template directly in a crystal of the thermostable Bacillus DNA polymerase I. The 6-bp extension involves a 20-Å translocation of the DNA duplex, representing the largest molecular movement observed in a protein crystal. In addition, we obtained the structure of a “closed” conformation of the enzyme with a bound triphosphate juxtaposed to a template and a dideoxy-terminated primer by constructing a point mutant that destroys a crystal lattice contact stabilizing the wild-type polymerase in an “open” conformation. Together, these observations allow many of the steps involved in DNA replication to be observed in the same enzyme at near atomic detail. The successive replication events observed directly by catalysis in the crystal confirm the general reaction sequence deduced from observations obtained by using several other polymerases and further refine critical aspects of the known reaction mechanism, and also allow us to propose new features that concern the regulated transfer of the template strand between a preinsertion site and an insertion site. We propose that such regulated transfer is an important element in the prevention of frameshift mutations in high-fidelity DNA polymerases. The ability to observe processive, high-fidelity replication directly in a crystal establishes this polymerase as a powerful model system for mechanistic studies in which the structural consequences of mismatches and DNA adducts are observed.


  • Reaction path of protein farnesyltransferase at atomic resolution

    by Stephen B. Long, Patrick J. Casey, Lorena S. Beese

    Protein farnesyltransferase (FTase) catalyses the attachment of a farnesyl lipid group to numerous essential signal transduction proteins, including members of the Ras superfamily1. The farnesylation of Ras oncoproteins, which are associated with 30% of human cancers, is essential for their transforming activity2. FTase inhibitors are currently in clinical trials for the treatment of cancer2,3,4. Here we present a complete series of structures representing the major steps along the reaction coordinate of this enzyme. From these observations can be deduced the determinants of substrate specificity and an unusual mechanism in which product release requires binding of substrate, analogous to classically processive enzymes. A structural model for the transition state consistent with previous mechanistic studies was also constructed. The processive nature of the reaction suggests the structural basis for the successive addition of two prenyl groups to Rab proteins by the homologous enzyme geranylgeranyltransferase type-II. Finally, known FTase inhibitors seem to differ in their mechanism of inhibiting the enzyme.


  • Open Access

    The crystal structure of human protein farnesyltransferase reveals the basis for inhibition by CaaX tetrapeptides and their mimetics

    by Stephen B. Long, Paula J. Hancock, Astrid M. Kral, Homme W. Hellinga, Lorena S. Beese

    Protein farnesyltransferase (FTase) catalyzes the attachment of a farnesyl lipid group to the cysteine residue located in the C-terminal tetrapeptide of many essential signal transduction proteins, including members of the Ras superfamily. Farnesylation is essential both for normal functioning of these proteins, and for the transforming activity of oncogenic mutants. Consequently FTase is an important target for anti-cancer therapeutics. Several FTase inhibitors are currently undergoing clinical trials for cancer treatment. Here, we present the crystal structure of human FTase, as well as ternary complexes with the TKCVFM hexapeptide substrate, CVFM non-substrate tetrapeptide, and L-739,750 peptidomimetic with either farnesyl diphosphate (FPP), or a nonreactive analogue. These structures reveal the structural mechanism of FTase inhibition. Some CaaX tetrapeptide inhibitors are not farnesylated, and are more effective inhibitors than farnesylated CaaX tetrapeptides. CVFM and L-739,750 are not farnesylated, because these inhibitors bind in a conformation that is distinct from the TKCVFM hexapeptide substrate. This non-substrate binding mode is stabilized by an ion pair between the peptide N terminus and the α-phosphate of the FPP substrate. Conformational mapping calculations reveal the basis for the sequence specificity in the third position of the CaaX motif that determines whether a tetrapeptide is a substrate or non-substrate. The presence of β-branched amino acids in this position prevents formation of the non-substrate conformation; all other aliphatic amino acids in this position are predicted to form the non-substrate conformation, provided their N terminus is available to bind to the FPP α-phosphate. These results may facilitate further development of FTase inhibitors.


  • 2 Structure of protein farnesyltransferase

    by Kimberly L. Terry, Stephen B. Long, Lorena S. Beese